These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35864749)

  • 1. Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor.
    Tang M; Sakasai S; Onishi H; Kawano K; Hattori Y
    J Drug Target; 2023 Jan; 31(1):74-88. PubMed ID: 35864749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells.
    Hattori Y; Shimizu S; Ozaki KI; Onishi H
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30991703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.
    Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H
    Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha.
    He Z; Yu Y; Zhang Y; Yan Y; Zheng Y; He J; Xie Y; He G; Wei Y; Song X
    J Biomed Nanotechnol; 2013 May; 9(5):833-44. PubMed ID: 23802413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery.
    Berger M; Toussaint F; Djemaa SB; Laloy J; Pendeville H; Evrard B; Jerôme C; Lechanteur A; Mottet D; Debuigne A; Piel G
    J Control Release; 2023 Sep; 361():87-101. PubMed ID: 37482343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
    Lee J; Ahn HJ
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic Liposomes Carrying HPV16 E6-siRNA Inhibit the Proliferation, Migration, and Invasion of Cervical Cancer Cells.
    Sánchez-Meza LV; Bello-Rios C; Eloy JO; Gómez-Gómez Y; Leyva-Vázquez MA; Petrilli R; Bernad-Bernad MJ; Lagunas-Martínez A; Medina LA; Serrano-Bello J; Organista-Nava J; Illades-Aguiar B
    Pharmaceutics; 2024 Jun; 16(7):. PubMed ID: 39065577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
    Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
    Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.
    Hattori Y; Saito H; Oku T; Ozaki KI
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs.
    Hattori Y; Tang M; Aoki A; Ezaki M; Sakai H; Ozaki KI
    Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.
    Li Y; Liu R; Shi Y; Zhang Z; Zhang X
    Theranostics; 2015; 5(6):583-96. PubMed ID: 25825598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
    Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
    Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA delivery into tumor cells by cationic cholesterol derivative-based nanoparticles and liposomes.
    Hattori Y; Hara E; Shingu Y; Minamiguchi D; Nakamura A; Arai S; Ohno H; Kawano K; Fujii N; Yonemochi E
    Biol Pharm Bull; 2015; 38(1):30-8. PubMed ID: 25744455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.
    Zhu Y; Cheng L; Cheng L; Huang F; Hu Q; Li L; Tian C; Wei L; Chen D
    Pharm Res; 2014 Dec; 31(12):3289-303. PubMed ID: 24858397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.